Neurol. praxi. 2011;12(2):104-109

Neuropathic component of chronic low back pain

MUDr.Tomáš Nedělka1,2,3, MUDr.Jiří Nedělka2, Ing.Jakub Schlenker3, MUDr.Radim Mazanec, Ph.D.1
1 Neurologická klinika UK 2. LF a FN Motol, Praha
2 Oddělení pro léčebnou rehabilitaci a léčbu bolesti Praha 6 –, Řepy
3 ČVUT v Praze, Fakulta biomedicínského inženýrství, Společné biomedicínské pracoviště ČVUT FBMI a UK 1. LF

Chronic low back pain (CBBP) is a common symptom affecting around 10 % of adult population in Western societies. Neuropathic component

is common, affecting around 1/3 of CBBP patients. It consists of local neuropathic pain within the degenerated intervertebral disc

and surrounding soft tissues as well as radicular pain which is caused by local nerve root compression, swelling or inflamation. Clinical

manifestation of neuropathic low back pain depends on affected nerve structures. Compression of nerve root or ventral rami of spinal

nerve usually causes sciatica. Symptoms of local neuropathic pain vary from latent trigger points or segmental tenderness (myofascial

pain syndrome) to abnormal skin sensations within the low back area. Presence of neuropathic pain has important impact upon analgetic

treatment, first line non-steroid antiflogistics (NSA) are effective in nociceptive pain only and does not have significant effect on

neuropathic component. Adjunct of tricyclic antidepressants, 3rd generation anticonvulsants such as pregabaline or gabapentine or

local anesthetic/steroid blocks can be beneficial in patients who do not respond to NSA in monotherapy. Non-pharmacotherapeutical

procedures – manipulation techniques, back school, physical therapy, accupuncture or psychotherapy are no less effective therapeutic

approaches, that can be used for complex treatment of chronic low back pain.

Keywords: chronic low back pain, neuropathic pain, degenerative spine disease

Published: June 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nedělka T, Nedělka J, Schlenker J, Mazanec R. Neuropathic component of chronic low back pain. Neurol. praxi. 2011;12(2):104-109.
Download citation

References

  1. Abdullah K, El Yaski AZ, Youseif E. Identifying neuropathic pain among patiens with chronic low back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale, Saudi Med J. 2004; 25(12): 1986-1990. Go to PubMed...
  2. Ambler Z. Neuropatická bolest - mechanizmus, příčiny a farmakoterapie, Neurol. prax 2007; 2: 102-106.
  3. Armon C, Argoff CE, Samuels J, Backonja MM. Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology., Neurology 2007; 68(10): 723-729. Go to original source... Go to PubMed...
  4. Assendelft WJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG. Spinal manipulative therapy for low back pain. Cochrane Database Syst Rev. 2004; (1): CD000447. Go to original source...
  5. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision., Eur J Neurol. 2010; 17(9): 1113-e88. Go to original source... Go to PubMed...
  6. Audette JF, Emenike E, Meleger AL. Neuropathic low back pain, Curr Pain Headache Rep. 2005; 9(3): 168-177. Go to original source... Go to PubMed...
  7. Audette JF, Wang F, Smith H. Bilateral activation of motor unit potentials with unilateral needle stimulation of active myofascial trigger points. Arch Phys Med Rehab 2004; 83: 368-374. Go to original source... Go to PubMed...
  8. Baron R, Binder A. How neuropathic is sciatica? The mixed pain concept. Orthopade. 2004; 33(5): 568-575. Go to original source... Go to PubMed...
  9. Barsa P, Häckel M. Systém, ,červených praporků" v diagnostice a terapii bolestí zad. Bolest 2004; Supplementum 2: 15-19.
  10. Bogduk N. Clinical Anatomy of the Lumbar Spine and Sacrum, edn 3. New York: Churchill Livingstone, 1997: 40-56.
  11. Bogduk N, McQuirk B. Medical management of acute and chronic low back pain. Pain Research and Clinical Management. Elsevier 2002: 115-204.
  12. Bogduk N, Tynan W, Wilson AS. Discography, in White and Schofferman, editors, Spine care, Mosby, St. Louis, 1995: 221-224.
  13. Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration, J Bone Joint Surg Am, 2006; 88(Suppl 2): 68-81. Go to original source... Go to PubMed...
  14. Crock HV, Internal disc disruption: a challenge to disc prolapse fifty years on, Spine 1986; 11: 650-653. Go to original source...
  15. DePalma MJ, Slipman CW. Evidence-informed management of chronic low back pain with epidural steroid injections. Spine J. 2008; 8(1): 45-55. Go to original source... Go to PubMed...
  16. Devillé WL, van der Windt DA, Dzaferagic A, Bezemer PD, Bouter LM. The test of Laségue: systematic review of the accuracy in diagnosing herniated discs. Spine. 2000; 25(9): 1140-1147. Go to original source... Go to PubMed...
  17. Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001; 344(5): 363-370. Go to original source... Go to PubMed...
  18. Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009; 13(3): 185-190. Go to original source... Go to PubMed...
  19. Freynhagen R, Baron R, Gockel U, Tölle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006; 22(10): 1911-1920. Go to original source... Go to PubMed...
  20. Furlan AD, van Tulder MW, Cherkin DC, et al. Acupuncture and dryneedling for low back pain. Cochrane Database Syst Rev. 2005; (1): CD001351. Go to original source...
  21. Galiano K, Obwegeser AA, Bodner G, Freund M, Maurer H, Kamelger FS, Schatzer R, Ploner F. Ultrasound guidance for facet joint injections in the lumbar spine: a computed tomography-controlled feasibility study. Anesth Analg. 2005; 101(2): 579-583. Go to original source... Go to PubMed...
  22. Groen GJ, Baljet B, Drukker J. Nerves and nerve plexuses of the human vertebral column. Am J Anat 1990; 188: 282-296. Go to original source... Go to PubMed...
  23. Hawkins J, Schofferman J. Serial therapeutic sacroiliac joint injections: a practice audit. Pain Med. 2009; 10(5): 850-853. Go to original source... Go to PubMed...
  24. Kawakami M, Kenici C, Weinstein J. In Spine care, Mosby, St. Louis, 1995: 92-94.
  25. Koes B, van Tulder M. Low back pain (acute). Clinical evidence 2006(15): 1619-1633. Go to original source...
  26. Liddle SD, Baxter GD, Gracey JH. Exercise and chronic low back pain: what works? Pain. 2004; 107(1-2): 176-190. Go to original source... Go to PubMed...
  27. Metodické pokyny pro farmakoterapii bolesti. Přepracované vydání. Bolest 2009; (Suppl 2): 4; 11-20.
  28. Moskowitz MH. Pharmacotherapy of neuropathic low back pain., Curr Pain Headache Rep. 2003; 7(3): 178-187. Review. Go to original source... Go to PubMed...
  29. Nedělka T, Nedělka J, Nosek M, Barták V, Kašpar J. Léčba rázovou vlnou u onemocnění pohybového ústrojí, Rehabil. fyz. lék., 2009; 16: 139-149.
  30. Opavský J, Rokyta R. Patofyziologie neuropatické bolesti. In: Rokyta R, Kršiak M, Kozák J. Bolest, Praha: Tigis, 2006: 245-246.
  31. Omarker K, Myers RR. Pathogenesis of sciatic pain: role of herniated nucleus pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain 1998; 78: 99-105. Go to original source... Go to PubMed...
  32. Selby D, The structure degenerative cascade - lumbar, in Spine care, Mosby. St. Louis, 1995: 15.
  33. Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol. 2005; 99(5): 1977-1984. Go to original source... Go to PubMed...
  34. Vrba I. Některé příčiny bolesti zad a jejich léčba, Neurol. pro praxi 2010; 11(3): 183-187.
  35. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain, Science 2000; 288: 1765-1788. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.